A servey of prophylactic effect of Mycophenolate Mofetil in delayed graft function and early outcome of living-kidney transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138901153623N1

Enrollment

Registered

2010-05-05

Start date

2009-03-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease. End-stage renal disease

Interventions

Treatment - Drugs

Placebo

Tab mycophenolate mofetil 1000 mg/bid 5 days before transplantation and placebo

Intervention 1: Tab mycophenolate mofetil 1000 mg/bid 5 days before transplantation and placebo. Intervention 2: Placebo.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: presence of end stage renal diseases who are candidates for renal transplantation Exclusion criteria: Second or more transplantation, cadaver transplantation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Plasma Cratinin. Timepoint: Daily. Method of measurement: Blood sample.	—

Secondary

Measure	Time frame
Rate of acute rejection. Timepoint: Daily. Method of measurement: Physical Examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Bahram Samadzadeh

Kermanshah University of Medical Sciences

bsamadzadeh@kums.ac.ir+98 83 1427 6309

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026